672 filings
Page 2 of 34
8-K
bgt47t1f5wcm591owuq1
11 Sep 23
Results of Operations and Financial Condition
6:24pm
8-K
wdrdakxa r9qvj
7 Sep 23
Results of Operations and Financial Condition
4:32pm
8-K
utwz4uz7xqeowgf5e
30 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
v6jxif5 9skyrjs
23 Aug 23
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors
6:50am
8-K
2wqenyh 45pshnw
9 Aug 23
ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
6:56am
S-8
5nl6k7d u3rs
23 Jun 23
Registration of securities for employees
1:59pm
8-K
436sum q1sue9
8 Jun 23
Results of Operations and Financial Condition
8:00pm
8-K
rcxrsb 4j
25 May 23
Departure of Directors or Certain Officers
4:31pm
8-K
o3ioqwe
16 May 23
Other Events
4:07pm
424B5
zev4htjze4i8
12 May 23
Prospectus supplement for primary offering
4:58pm
8-K
p6l3i6sia
12 May 23
Ani Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock
4:56pm
8-K
7t8futxq 59slm1x6tk
11 May 23
Ani Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:02pm
424B5
i4pv8dbw
11 May 23
Prospectus supplement for primary offering
4:01pm
DEFA14A
2eieh1wpaogah7pix7nq
8 May 23
Additional proxy soliciting materials
8:35am
8-K
rn88zba6c1xwhtug
8 May 23
Departure of Directors or Certain Officers
8:33am
8-K
yv64 opzp
8 May 23
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
8:31am
DEFA14A
ifa6wou7a z4
11 Apr 23
Additional proxy soliciting materials
4:36pm